MOLECULAR TESTING AND CYTOPATHOLOGIC FEATURES OF MALIGNANT PLEURAL EFFUSION IN PATIENTS WITH NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Fujii, T.
Fukawa, T.
Kishi, K.
Ohashi, K.
机构：
[1] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan
[2] Toranomon Gen Hosp, Dept Resp Med, Tokyo, Japan
[3] Resp Ctr, Tokyo, Japan
来源：
ACTA CYTOLOGICA | 2010年 / 54卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：414 / 414
页数：1
相关论文
共 50 条
  • [1] Clinical and Molecular Features of Malignant Pleural Effusion in Non-Small Cell Lung Cancer (NSCLC) of a Caucasian Population
    Lojo-Rodriguez, Irene
    Botana-Rial, Maribel
    Gonzalez-Montaos, Almudena
    Leiro-Fernandez, Virginia
    Gonzalez-Pineiro, Ana
    Ramos-Hernandez, Cristina
    Fernandez-Villar, Alberto
    MEDICINA-LITHUANIA, 2024, 60 (11):
  • [2] Role of molecular testing for malignant pleural effusion in targeted therapy for advanced non-small cell lung cancer
    Lin, Rixu
    Li, Yida
    Lin, Yi
    Tian, Wenyi
    Jiang, Lei
    Li, Jianmin
    DIAGNOSTIC CYTOPATHOLOGY, 2023, 51 (07) : 397 - 405
  • [3] Molecular profile of malignant pleural effusion (MPE) in non-small cell lung cancer (NSCLC)
    Rodriguez, Irene Lojo
    Rial, Maribel Botana
    Montaos, Almudena Gonzalez
    Pineiro, Ana Gonzalez
    Hernandez, Cristina Ramos
    Delgado, Mercedes Cuna
    Delgado, Manuel Nunez
    Villar, Alberto Fernandez
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [4] Predictive model for sarcopenia in patients with non-small cell lung cancer and malignant pleural effusion
    Gao, Hengxing
    Zou, Xuexue
    Fan, Meng
    Chen, Mingwei
    BMC CANCER, 2025, 25 (01)
  • [5] Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small Cell Lung Carcinoma
    Carter, Jamal H.
    Miller, James A.
    Maleki, Zahra
    LABORATORY INVESTIGATION, 2016, 96 : 94A - 94A
  • [6] Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small Cell Lung Carcinoma
    Carter, Jamal H.
    Miller, James A.
    Maleki, Zahra
    MODERN PATHOLOGY, 2016, 29 : 94A - 94A
  • [7] Does the Amount of Malignant Pleural Effusion Affect the Survival in Patients with Non-Small Cell Lung Cancer?
    Nakamura, Shota
    Okasaka, Toshiki
    Kawaguchi, Koji
    Fukui, Takayuki
    Fukumoto, Koichi
    Yokoi, Kohei
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S727 - S727
  • [8] The therapeutic efficacy of osimertinib in non-small cell lung cancer with malignant pleural effusion
    Nagamine, Hiroaki
    Sawa, Kenji
    Kaneda, Hiroyasu
    Ogawa, Koichi
    Nakahama, Kenji
    Matsumoto, Yoshiya
    Tani, Yoko
    Mitsuoka, Shigeki
    Kimura, Tatsuo
    Kawaguchi, Tomoya
    ANNALS OF ONCOLOGY, 2022, 33 : S523 - S523
  • [9] The prognostic significance of malignant pleural effusion at the time of thoracotomy in patients with non-small cell lung cancer
    Fukuse, T
    Hirata, T
    Tanaka, F
    Wada, H
    LUNG CANCER, 2001, 34 (01) : 75 - 81
  • [10] The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer
    Chen, Yao
    Mathy, Nicholas W.
    Lu, Hongda
    MOLECULAR MEDICINE REPORTS, 2018, 17 (06) : 8019 - 8030
12345